Skip to NavigationSkip to content

News

0
Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy and pipeline”....
0
The Centers for Disease Control and Prevention (CDC) confirms that COVID-19 is less severe in children than adults.
0
Eli Lilly announced that it will limit out of pocket costs for insulin to $35 per month to offset the financial conditions created by the coronavirus.
0
Gilead and microbiome science specialist Second Genome have announced they are to partner up to advance a selection of the former’s therapeutics in a...

Features

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry better...